Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Infectious Disease
•
Allergy & Immunology
•
Dermatology
•
Internal Medicine
What is your diagnostic approach to mild, chronic eosinophilia with AEC <1500?
When would a patient qualify for anti-IL5 therapy?
How to choose between IL-4, IL-5, or IL-13?
Related Questions
Do you recommend lifelong antibiotic prophylaxis, or do you prefer a more selective approach based on risk factors in asplenic patients without a history of severe infections?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
What treatment combination approach would you recommend for mucous membrane pemphigoid?
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?
What is your preferred oral regime with duration for treatment of onychomycosis?
How would you manage LPL with associated AL amyloidosis?